| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.01B | +266.6% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 43.9% | Net margin -88.2% |
| Revenue Q/Q | -84.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.01B | 56.1% |
| R&D | ¥0.00B | 40.1% |
| SG&A | ¥0.01B | 50.8% |
| Tax & other | ¥-0.00B | -6.8% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
英飞特 ・ 赛托生物 ・ 海辰药业 ・ 奥联电子 ・ 美联新材 ・ 天铁科技 ・ 熙菱信息 ・ 江龙船艇 ・ 移为通信 ・ 万里马 ・ 华凯易佰 ・ 新雷能
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies